Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.

Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, D'Egidio A, Cecchini V, Landoni G, Pietropaoli P, Westphal M, Venditti M, Mebazaa A, Singer M.

Crit Care Med. 2013 Sep;41(9):2162-8. doi: 10.1097/CCM.0b013e31828a678d.

PMID:
23873274
2.

Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.

Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M.

JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477.

PMID:
24108526
3.

Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.

Morelli A, Donati A, Ertmer C, Rehberg S, Orecchioni A, Di Russo A, Pelaia P, Pietropaoli P, Westphal M.

Intensive Care Med. 2011 Jun;37(6):963-9. doi: 10.1007/s00134-011-2148-x. Epub 2011 Feb 19.

PMID:
21336777
4.

[Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate].

Xinqiang L, Weiping H, Miaoyun W, Wenxin Z, Wenqiang J, Shenglong C, Juhao Z, Hongki Z.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Sep;27(9):759-63. Chinese.

5.

Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.

Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D.

Intensive Care Med. 2011 Aug;37(8):1344-51. doi: 10.1007/s00134-011-2236-y. Epub 2011 May 13.

PMID:
21567116
6.

Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.

Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, Di Russo A, D'Egidio A, Landoni G, Lombrano MR, Botticelli L, Valentini A, Zangrillo A, Pietropaoli P, Westphal M.

Crit Care. 2011;15(5):R217. doi: 10.1186/cc10453. Epub 2011 Sep 19.

7.

[Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].

Yang S, Liu Z, Yang W, Zhang G, Hou B, Liu J, Shi Q.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Oct;26(10):714-7. doi: 10.3760/cma.j.issn.2095-4352.2014.10.007. Chinese.

8.

Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.

Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T.

Crit Care Med. 1999 Sep;27(9):1708-13.

PMID:
10507587
9.

[Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].

Tao Y, Jingyi W, Xiaogan J, Weihua L, Xiaoju J.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Nov;27(11):885-9. Chinese.

PMID:
27132454
10.

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.

Albanèse J, Leone M, Delmas A, Martin C.

Crit Care Med. 2005 Sep;33(9):1897-902.

PMID:
16148457
11.

Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study.

van Haren FM, Sleigh J, Boerma EC, La Pine M, Bahr M, Pickkers P, van der Hoeven JG.

Shock. 2012 Mar;37(3):268-75. doi: 10.1097/SHK.0b013e31823f152f.

PMID:
22089205
12.

Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock.

Balik M, Rulisek J, Leden P, Zakharchenko M, Otahal M, Bartakova H, Korinek J.

Wien Klin Wochenschr. 2012 Aug;124(15-16):552-6. Epub 2012 Jul 20.

PMID:
22815003
13.

[Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients].

Chen JX, Sun J, Liu YY, Jia BH.

Zhonghua Yi Xue Za Zhi. 2013 Apr 23;93(16):1243-6. Chinese.

PMID:
23902616
14.

Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock.

Edul VS, Enrico C, Laviolle B, Vazquez AR, Ince C, Dubin A.

Crit Care Med. 2012 May;40(5):1443-8. doi: 10.1097/CCM.0b013e31823dae59.

PMID:
22430243
15.

Esmolol for septic shock: more than just heart rate control?

Orbegozo Cortes D, Njimi H, Dell'Anna AM, Taccone FS.

Minerva Anestesiol. 2014 Feb;80(2):254-8.

16.

Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.

Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.

Pediatrics. 2006 Jul;118(1):e76-84. Epub 2006 Jun 2.

PMID:
16751617
17.

Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.

Du W, Wang XT, Long Y, Liu DW.

Chin Med J (Engl). 2016 Jul 20;129(14):1658-65. doi: 10.4103/0366-6999.185856.

18.

Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.

Jacquet-Lagrèze M, Allaouchiche B, Restagno D, Paquet C, Ayoub JY, Etienne J, Vandenesch F, Dauwalder O, Bonnet JM, Junot S.

Crit Care. 2015 Jun 4;19:241. doi: 10.1186/s13054-015-0960-3.

19.

Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.

Jellema WT, Groeneveld AB, Wesseling KH, Thijs LG, Westerhof N, van Lieshout JJ.

Crit Care Med. 2006 Sep;34(9):2392-8.

PMID:
16849997
20.

Sublingual microcirculatory changes during high-volume hemofiltration in hyperdynamic septic shock patients.

Ruiz C, Hernandez G, Godoy C, Downey P, Andresen M, Bruhn A.

Crit Care. 2010;14(5):R170. doi: 10.1186/cc9271. Epub 2010 Sep 27.

Supplemental Content

Support Center